THE R21/MATRIX-M (TM) MALARIA VACCINE CANDIDATE: A PHASE III TRIAL.
2021
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2021).105 5
2021
BMC Med, (2021).19 1 10.1186/s12916-021-02127-w.
2021
Nature communications, (2021).12 1 10.1038/s41467-021-26452-z.
2021
BMJ global health, (2021).6 10 10.1136/bmjgh-2021-007124.
2021
Vaccines, (2021).9 11 10.3390/vaccines9111228.
2021
medRxiv (2021). 10.1101/2021.10.20.21265245.
2021
European journal of pediatrics, (2021).181 3 10.1007/s00431-021-04272-z.
2021
The Journal of infectious diseases, (2021).225 5 10.1093/infdis/jiab489.
2021
JMIR Medical Informatics, (2021).9 10 10.2196/29584.
2021
The Lancet Infectious Diseases, (2021).21 12 10.1016/S1473-3099(21)00193-6.
